Literature DB >> 6093802

Brain CCK receptors are structurally distinct from pancreas CCK receptors.

C Sakamoto, J A Williams, I D Goldfine.   

Abstract

Brain and pancreas cholecystokinin (CCK) receptors differ markedly in their selectivity for CCK analogs. To determine the size and subunit structure of the brain CCK receptor and compare it to that of the pancreas, 125I-CCK33 was covalently cross-linked with ultraviolet light to its receptor on mouse brain particles and purified pancreatic plasma membranes. When CCK was crosslinked to brain membranes, a single consistent major labeled protein band of Mr = 55,000 was observed in both the presence and the absence of DTT. These data with brain receptors contrast to results with pancreatic receptors where two bands of Mr = 120,000 and 80,000 are labeled in the absence and presence of DTT, respectively. These studies indicate, therefore, that the brain and pancreas CCK receptors are structurally and functionally distinct.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6093802     DOI: 10.1016/0006-291x(84)91581-x

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  Evidence for a common evolutionary origin of brain and pancreas cholecystokinin receptors.

Authors:  S R Vigna; M C Thorndyke; J A Williams
Journal:  Proc Natl Acad Sci U S A       Date:  1986-06       Impact factor: 11.205

2.  Cyclic cholecystokinin analogues with high selectivity for central receptors.

Authors:  B Charpentier; D Pelaprat; C Durieux; A Dor; M Reibaud; J C Blanchard; B P Roques
Journal:  Proc Natl Acad Sci U S A       Date:  1988-03       Impact factor: 11.205

3.  Opposite role of CCKA and CCKB receptors in the modulation of endogenous enkephalin antidepressant-like effects.

Authors:  C Smadja; R Maldonado; S Turcaud; M C Fournie-Zaluski; B P Roques
Journal:  Psychopharmacology (Berl)       Date:  1995-08       Impact factor: 4.530

4.  Biochemical and pharmacological characterization of an extremely potent and selective nonpeptide cholecystokinin antagonist.

Authors:  R S Chang; V J Lotti
Journal:  Proc Natl Acad Sci U S A       Date:  1986-07       Impact factor: 11.205

Review 5.  Perspectives of CCK antagonists in pancreatic research. Part II. Experimental studies.

Authors:  T Takács; A Pap
Journal:  Int J Pancreatol       Date:  1991-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.